Va Tech Wabag Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Va Tech Wabag Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Va Tech Wabag Ltd.
Rating: 5
Author: Axis Direct

Keep track of all breaking news and updates on Va Tech Wabag Ltd. from all sources in a single place.

Load latest

Va Tech Wabag Ltd.

23 Nov 2024

1310.40

1.97%

Pick of the Week:25 November 2024

Buy: Va Tech Wabag Ltd.

Target

Axis Direct

We recommend a BUY on the stock with a near-term TP of Rs 1,860/Share, implying an upside of 10% from the CMP

Va Tech Wabag Ltd. has gained 38.66% in the last 1 Year

Va Tech Wabag Ltd.

18 Nov 2024

1310.40

1.97%

Company Update

VA TECH WABAG LTD. - 533269 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Intimation of Schedule of Analysts / Institutional Investors Meeting

pdf

Va Tech Wabag Ltd.

15 Nov 2024

1310.40

1.97%

Trump picks Robert Kennedy as health secy, Doug Collins for Veteran Affairs

Business Standard

US President-elect Donald Trump on Thursday announced his decision to nominate former Democratic presidential candidate Robert F Kennedy Jr. as his Secretary of Health and Human Services. The nomination for this top Cabinet position is subject to confirmation by the US Senate. Trump also announced his intent to nominate former Congressman Doug Collins of Georgia as Secretary for Veterans Affairs (VA). "I am thrilled to announce Robert F Kennedy Jr. as The United States Secretary of Health and Human Services (HHS)," he said. For too long, Americans have been crushed by the industrial food complex and drug companies who have engaged in deception, misinformation, and disinformation when it came to public health, the president-elect said, indicating the health policies of his second term beginning January 20, 2025. Trump said the safety and health of all Americans is the most important role of any administration, and HHS will play a big role in helping ensure that everyone is protecte

Va Tech Wabag Ltd. has lost -26.10% in the last 6 Months

Va Tech Wabag Ltd.

14 Nov 2024

1310.40

1.97%

Earnings Call

VA TECH WABAG LTD. - 533269 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the ''Q2-H1 FY25 Results Conference Call''

pdf

Va Tech Wabag Ltd.

11 Nov 2024

1310.40

1.97%

Result Update:Va Tech Wabag

Buy: Va Tech Wabag Ltd.

Target

Axis Direct

We maintain our BUY rating on this stock.

Va Tech Wabag Ltd. has gained 38.66% in the last 1 Year

Va Tech Wabag Ltd.

11 Nov 2024

1310.40

1.97%

VA Tech Wabag

Buy: Va Tech Wabag Ltd.

Target

ICICI Direct

Va Tech Wabag Ltd. has gained 38.66% in the last 1 Year

Va Tech Wabag Ltd.

08 Nov 2024

1310.40

1.97%

Earnings Call

VA TECH WABAG LTD. - 533269 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Audio recording of 'Q2-H1 FY25 Results Conference Call' of VA TECH WABAG LIMITED

pdf

Va Tech Wabag Ltd.

08 Nov 2024

1310.40

1.97%

Company Update

VA TECH WABAG LTD. - 533269 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper advertisement titled "Extract of Statement of Consolidated Financial Results (Un-audited) for the quarter and half year ended September 30, 2024

pdf

Va Tech Wabag Ltd.

08 Nov 2024

1310.40

1.97%

Decent Q2; strong orderbook to drive growth

Buy: Va Tech Wabag Ltd.

Target

Sharekhan

Va Tech Wabag’s adjusted net profit increased 27.8% y-o-y to Rs. 70 crore. Revenue of Rs. 700 crore grew 5.3% y-o-y and OPM stood at 13.4%, up 42 bps y-o-y.

Va Tech Wabag Ltd. has gained 38.66% in the last 1 Year

Va Tech Wabag Ltd.

07 Nov 2024

1310.40

1.97%

Investor Presentation

VA TECH WABAG LTD. - 533269 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on the Unaudited Financial Results (both standalone and consolidated) of the Company for the quarter and half year ended September 30, 2024

pdf

Is Va Tech Wabag Ltd. worth buying?

368 Votes:

Buy 80.16%

Sell 11.68%

Hold 8.15%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf